GLYCOPEPTIDES AND LINEZOLID MIC CHANGES IN STAPHYLOCOCCUS AUREUS AND COAGULASE NEGATIVE STAPHYLOCOCCI ISOLATES FROM 2008-2011

Date
2014
Author
CAYCI, Yeliz Tanriverdi
Gunaydin, Murat
Yilmaz, Hava
Karadag, Adil
Esen, Saban
Yanik, Kerametrin
Metadata
Show full item record
Abstract
Aims: Glycopeptides and linezolid are the antimicrobial agents used for the treatment of methicillin resistant Staphylococcus aureus (MRSA) and methicillin resistant Coagulase negative Staphylococci (MRCoNS) infections. It is emerging concern about an increase minimum inhibitor concentration (MIC) of vacomycin among S. aureus strains. In this study, we aimed to analyse the trends in MICs of vancomycin, teicoplanin and linezolid over 4 years (2008-2011) period.
URI
http://hdl.handle.net/20.500.12627/90151
Collections